Komori
Other Disclosures2395SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.Information and Communications, Services and Others

SNBL INA, a consolidated subsidiary, has maintained its full accreditation from AAALAC International

SNBL INA, a consolidated subsidiary, maintained its full accreditation from AAALAC International and received notification of the accreditation.

Worth reading
57In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
8
8th accreditation renewal in total
Wording
Definitive
How definitive the wording is.

Announced details

AAALAC International full accreditation
Applicable field (uses covered by this announcement)

Laboratory animal care and use, pharmaceutical and biotechnology companies, universities, hospitals, research institutions and CROs

What the company reported numerically
Usage history

SNBL INA has maintained its full accreditation 8 times in total since 2005.

Relationship between the counterparty and the company
SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.2395
Relationship with the Company

The relationship between the accreditation body and the company's consolidated subsidiary that renewed its accreditation.

CounterpartyAAALAC International (international association for laboratory animal care assessment and accreditation)

A private, nongovernmental organization and independent international accreditation body headquartered in the United States that promotes the humane care and use of animals in science. It accredits more than 1,175 organizations in 52 countries and regions. Accredited facilities undergo reassessment through site visits once every 3 years.

Award/certification name

AAALAC International full accreditation

Awarding / certifying body

AAALAC International (international association for laboratory animal care assessment and accreditation)

Impact on Business Performance

The company explains that accreditation is an important prerequisite for many pharmaceutical companies, particularly customers in Europe and the United States, when outsourcing work to CROs, but no specific amount of impact on financial results is stated.

The company does not address Contract Value / Offering price.

Source (materials cited by the company)

AAALAC International

Announced details
ItemDetails
Names of Products / Services CoveredAAALAC International full accreditation
CounterpartyAAALAC International (international association for laboratory animal care assessment and accreditation)
Counterparty overviewA private, nongovernmental organization and independent international accreditation body headquartered in the United States that promotes the humane care and use of animals in science. It accredits more than 1,175 organizations in 52 countries and regions. Accredited facilities undergo reassessment through site visits once every 3 years.
Relationship with the CompanyThe relationship between the accreditation body and the company's consolidated subsidiary that renewed its accreditation.
Applicable areaLaboratory animal care and use, pharmaceutical and biotechnology companies, universities, hospitals, research institutions and CROs
Award/certification nameAAALAC International full accreditation
Awarding / certifying bodyAAALAC International (international association for laboratory animal care assessment and accreditation)
Usage historySNBL INA has maintained its full accreditation 8 times in total since 2005.
Impact on Business PerformanceThe company explains that accreditation is an important prerequisite for many pharmaceutical companies, particularly customers in Europe and the United States, when outsourcing work to CROs, but no specific amount of impact on financial results is stated.
SourceAAALAC International
Items this document does not state (8)
Contract ValueOffering priceContract DateLaunch dateRegistration number and expiry dateLocationLocation scaleQuantitative Effects

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The quality of its animal care and its commitment to the program were highly evaluated.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
SNBL INA, a consolidated subsidiary, has maintained its full accreditation from AAALAC International | SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. (2395) timely disclosure | Komori